{
    "nct_id": "NCT04947124",
    "official_title": "Masked, Randomized, Single-site, Crossover Study to Determine the Safety and Tolerability of 2 Concentrations of QLS-101 Dosed for 14 Days in Adult Subjects With Sturge-Weber Syndrome (SWS)-Related Glaucoma Due to Elevated Episcleral Venous Pressure (EVP)",
    "inclusion_criteria": "* Diagnosed with SWS.\n* Elevated intraocular pressure (IOP)\n* Willing to continue current dosing regimen of IOP-lowering medications\n* Willing to refrain from contact lens use in the study eye.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* IOP with variability of > 4 mm Hg\n* Expected to undergo IOP-lowering surgery\n* Incisional or laser surgery of any type\n* Ocular infection, inflammation, clinically significant blepharitis or conjunctivitis\n* A history of herpes simplex keratitis in either eye.\n* History of or active clinically significant ocular disease\n* Use of topical ocular corticosteroids in the 6 weeks prior to Visit 1",
    "miscellaneous_criteria": ""
}